| Year |
Citation |
Score |
| 2024 |
Rogers BB, Anderson AG, Lauzon SN, Davis MN, Hauser RM, Roberts SC, Rodriguez-Nunez I, Trausch-Lowther K, Barinaga EA, Hall PI, Knuesel MT, Taylor JW, Mackiewicz M, Roberts BS, Cooper SJ, ... ... Cochran JN, et al. Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements. American Journal of Human Genetics. PMID 38232730 DOI: 10.1016/j.ajhg.2023.12.015 |
0.675 |
|
| 2023 |
Roth JR, Rush T, Thompson SJ, Aldaher AR, Dunn TB, Mesina JS, Cochran JN, Boyle NR, Dean HB, Yang Z, Pathak V, Ruiz P, Wu M, Day JJ, Bostwick JR, et al. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 21: e00291. PMID 38241154 DOI: 10.1016/j.neurot.2023.10.001 |
0.696 |
|
| 2023 |
Snyder A, Ryan VH, Hawrot J, Lawton S, Ramos DM, Qi YA, Johnson K, Reed X, Johnson NL, Kollasch AW, Duffy M, VandeVrede L, Cochran JN, Miller BL, Toro C, et al. An P93S variant dysregulates TDP-43 and causes corticobasal syndrome. Research Square. PMID 37886540 DOI: 10.21203/rs.3.rs-3462973/v1 |
0.457 |
|
| 2023 |
Mantyh WG, Cochran JN, Taylor JW, Broce IJ, Geier EG, Bonham LW, Anderson AG, Sirkis DW, Joie R, Iaccarino L, Chaudhary K, Edwards L, Strom A, Grant H, Allen IE, et al. Early-onset Alzheimer's disease explained by polygenic risk of late-onset disease? Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12482. PMID 37780862 DOI: 10.1002/dad2.12482 |
0.5 |
|
| 2023 |
de Ávila C, Suazo C, Nolz J, Cochran JN, Wang Q, Velazquez R, Dammer E, Readhead B, Mastroeni D. Reduced gene expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes. Biorxiv : the Preprint Server For Biology. PMID 37645898 DOI: 10.1101/2023.08.14.553279 |
0.355 |
|
| 2023 |
Wright CA, Taylor JW, Cochran M, Lawlor JMJ, Moyers BA, Amaral MD, Bonnstetter ZT, Carter P, Solomon V, Myers RM, Love MN, Geldmacher DS, Cooper SJ, Roberson ED, Cochran JN. Contributions of rare and common variation to early-onset and atypical dementia risk. Cold Spring Harbor Molecular Case Studies. PMID 37308299 DOI: 10.1101/mcs.a006271 |
0.727 |
|
| 2023 |
Rogers BB, Anderson AG, Lauzon SN, Davis MN, Hauser RM, Roberts SC, Rodriguez-Nunez I, Trausch-Lowther K, Barinaga EA, Taylor JW, Mackiewicz M, Roberts BS, Cooper SJ, Rizzardi LF, Myers RM, ... Cochran JN, et al. expression is mediated by long-range interactions with -regulatory elements. Biorxiv : the Preprint Server For Biology. PMID 37090552 DOI: 10.1101/2023.03.07.531520 |
0.643 |
|
| 2023 |
Cochran JN, Acosta-Uribe J, Esposito BT, Madrigal L, Aguillón D, Giraldo MM, Taylor JW, Bradley J, Fulton-Howard B, Andrews SJ, Acosta-Baena N, Alzate D, Garcia GP, Piedrahita F, Lopez HE, et al. Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36951251 DOI: 10.1002/alz.13021 |
0.543 |
|
| 2023 |
Anderson AG, Rogers BB, Loupe JM, Rodriguez-Nunez I, Roberts SC, White LM, Brazell JN, Bunney WE, Bunney BG, Watson SJ, Cochran JN, Myers RM, Rizzardi LF. Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer's disease-specific -regulatory elements. Cell Genomics. 3: 100263. PMID 36950385 DOI: 10.1016/j.xgen.2023.100263 |
0.556 |
|
| 2023 |
Wright CA, Taylor JW, Cochran M, Lawlor JMJ, Moyers BA, Amaral MD, Bonnstetter ZT, Carter P, Solomon V, Myers RM, Love MN, Geldmacher DS, Cooper SJ, Roberson ED, Cochran JN. Contributions of rare and common variation to early-onset and atypical dementia risk. Medrxiv : the Preprint Server For Health Sciences. PMID 36798301 DOI: 10.1101/2023.02.06.23285383 |
0.727 |
|
| 2022 |
Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, van Rooij JGJ, Sims R, Ahmad S, Amin N, Norsworthy PJ, Dols-Icardo O, Hummerich H, Kawalia A, Amouyel P, ... ... Cochran JN, et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. Nature Genetics. PMID 36411364 DOI: 10.1038/s41588-022-01208-7 |
0.596 |
|
| 2022 |
Acosta-Uribe J, Aguillón D, Cochran JN, Giraldo M, Madrigal L, Killingsworth BW, Singhal R, Labib S, Alzate D, Velilla L, Moreno S, García GP, Saldarriaga A, Piedrahita F, Hincapié L, et al. A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects. Genome Medicine. 14: 27. PMID 35260199 DOI: 10.1186/s13073-022-01035-9 |
0.41 |
|
| 2021 |
Ibanez A, Yokoyama JS, Possin KL, Matallana D, Lopera F, Nitrini R, Takada LT, Custodio N, Sosa Ortiz AL, Avila-Funes JA, Behrens MI, Slachevsky A, Myers RM, Cochran JN, Brusco LI, et al. The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science. Frontiers in Neurology. 12: 631722. PMID 33776890 DOI: 10.3389/fneur.2021.631722 |
0.518 |
|
| 2021 |
Voskobiynyk Y, Battu G, Felker SA, Cochran JN, Newton MP, Lambert LJ, Kesterson RA, Myers RM, Cooper GM, Roberson ED, Barsh GS. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy. Plos Genetics. 17: e1009195. PMID 33411788 DOI: 10.1371/journal.pgen.1009195 |
0.712 |
|
| 2020 |
Graff EC, Cochran JN, Kaelin CB, Day K, Gray-Edwards HL, Watanabe R, Koehler JW, Falgoust RA, Prokop JW, Myers RM, Cox NR, Barsh GS, Martin DR. PEA15 loss of function and defective cerebral development in the domestic cat. Plos Genetics. 16: e1008671. PMID 33290415 DOI: 10.1371/journal.pgen.1008671 |
0.457 |
|
| 2020 |
Cochran JN, Myers RM, Yokoyama JS. Response to Holstege et al. American Journal of Human Genetics. 107: 577-578. PMID 32888508 DOI: 10.1016/J.Ajhg.2020.07.012 |
0.312 |
|
| 2020 |
Voskobiynyk Y, Roth JR, Cochran JN, Rush T, Carullo NV, Mesina JS, Waqas M, Vollmer RM, Day JJ, McMahon LL, Roberson ED. Alzheimer's disease risk gene induces Tau-dependent network hyperexcitability. Elife. 9. PMID 32657270 DOI: 10.7554/Elife.57354 |
0.722 |
|
| 2020 |
Cochran JN, Geier EG, Bonham LW, Newberry JS, Amaral MD, Thompson ML, Lasseigne BN, Karydas AM, Roberson ED, Cooper GM, Rabinovici GD, Miller BL, Myers RM, Yokoyama JS. Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases. American Journal of Human Genetics. PMID 32330418 DOI: 10.1016/J.Ajhg.2020.03.010 |
0.759 |
|
| 2019 |
Cochran JN, McKinley EC, Cochran M, Amaral MD, Moyers BA, Lasseigne BN, Gray DE, Lawlor JMJ, Prokop JW, Geier EG, Holt JM, Thompson ML, Newberry JS, Yokoyama JS, Worthey EA, et al. Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles. Cold Spring Harbor Molecular Case Studies. 5. PMID 31836585 DOI: 10.1101/mcs.a003491 |
0.751 |
|
| 2019 |
Rush T, Roth JR, Thompson SJ, Aldaher AR, Cochran JN, Roberson ED. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity. Neurobiology of Disease. 104668. PMID 31698056 DOI: 10.1016/J.Nbd.2019.104668 |
0.734 |
|
| 2019 |
Ramirez Aguilar L, Acosta-Uribe J, Giraldo MM, Moreno S, Baena A, Alzate D, Cuastumal R, Aguillón D, Madrigal L, Saldarriaga A, Navarro A, Garcia GP, Aguirre-Acevedo DC, Geier EG, Cochran JN, et al. Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30745123 DOI: 10.1016/J.Jalz.2018.12.010 |
0.517 |
|
| 2018 |
Carvill GL, Engel KL, Ramamurthy A, Cochran JN, Roovers J, Stamberger H, Lim N, Schneider AL, Hollingsworth G, Holder DH, Regan BM, Lawlor J, Lagae L, Ceulemans B, Bebin EM, et al. Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies. American Journal of Human Genetics. 103: 1022-1029. PMID 30526861 DOI: 10.1016/J.Ajhg.2018.10.023 |
0.51 |
|
| 2018 |
Geier EG, Bourdenx M, Storm NJ, Cochran JN, Sirkis DW, Hwang JH, Bonham LW, Ramos EM, Diaz A, Van Berlo V, Dokuru D, Nana AL, Karydas A, Balestra ME, Huang Y, et al. Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathologica. PMID 30382371 DOI: 10.1007/S00401-018-1925-9 |
0.618 |
|
| 2018 |
Hiatt SM, Amaral MD, Bowling KM, Finnila CR, Thompson ML, Gray DE, Lawlor JMJ, Cochran JN, Bebin EM, Brothers KB, East KM, Kelley WV, Lamb NE, Levy SE, Lose EJ, et al. Systematic reanalysis of genomic data improves quality of variant interpretation. Clinical Genetics. PMID 29652076 DOI: 10.1111/Cge.13259 |
0.452 |
|
| 2017 |
Bowling KM, Thompson ML, Amaral MD, Finnila CR, Hiatt SM, Engel KL, Cochran JN, Brothers KB, East KM, Gray DE, Kelley WV, Lamb NE, Lose EJ, Rich CA, Simmons S, et al. Genomic diagnosis for children with intellectual disability and/or developmental delay. Genome Medicine. 9: 43. PMID 28554332 DOI: 10.1186/S13073-017-0433-1 |
0.426 |
|
| 2016 |
Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiology of Aging. PMID 27793474 DOI: 10.1016/J.Neurobiolaging.2016.09.020 |
0.569 |
|
| 2015 |
Cochran JN, Rush T, Buckingham SC, Roberson ED. The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity. Human Molecular Genetics. PMID 26358779 DOI: 10.1093/hmg/ddv371 |
0.664 |
|
| 2014 |
Cochran JN, Diggs PV, Nebane NM, Rasmussen L, White EL, Bostwick R, Maddry JA, Suto MJ, Roberson ED. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease. Journal of Biomolecular Screening. 19: 1338-49. PMID 25156556 DOI: 10.1177/1087057114547232 |
0.586 |
|
| 2014 |
Cochran JN, Hall AM, Roberson ED. The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Research Bulletin. 103: 18-28. PMID 24333192 DOI: 10.1016/J.Brainresbull.2013.12.004 |
0.694 |
|
| 2013 |
Seward ME, Swanson E, Norambuena A, Reimann A, Cochran JN, Li R, Roberson ED, Bloom GS. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease. Journal of Cell Science. 126: 1278-86. PMID 23345405 DOI: 10.1242/Jcs.1125880 |
0.596 |
|
| Show low-probability matches. |
